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Abstract
Objective: Previous tissue engineering approaches to create small caliber vascular grafts have been limited by the structural and
mechanical immaturity of the constructs. This study uses a novel in vitro pulse duplicator system providing a `biomimetic' environment
during tissue formation to yield more mature, implantable vascular grafts. Methods: Vascular grafts (I.D. 0.5 cm) were fabricated from novel
bioabsorbable polymers (polyglycolic-acid/poly-4-hydroxybutyrate) and sequentially seeded with ovine vascular myo®broblasts and
endothelial cells. After 4 days static culture, the grafts (n  24) were grown in vitro in a pulse duplicator system (bioreactor) for 4, 7,
14, 21, and 28 days. Controls (n  24) were grown in static culture conditions. Analysis of the neo-tissue included histology, scanning
electron microscopy (SEM), and biochemical assays (DNA for cell content, 5-hydroxyproline for collagen). Mechanical testing was
performed measuring the burst pressure and the suture retention strength. Results: Histology showed viable, dense tissue in all samples.
SEM demonstrated con¯uent smooth inner surfaces of the grafts exposed to pulsatile ¯ow after 14 days. Biochemical analysis revealed a
continuous increase of cell mass and collagen to 21 days compared to signi®cantly lower values in the static controls. The mechanical
properties of the pulsed vascular grafts comprised supra-physiological burst strength and suture retention strength appropriate for surgical
implantation. Conclusions: This study demonstrates the feasibility of tissue engineering of viable, surgically implantable small caliber
vascular grafts and the important effect of a `biomimetic' in vitro environment on tissue maturation and extracellular matrix formation.
q 2001 Elsevier Science B.V. All rights reserved.
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1. Introduction
Atherosclerotic vascular disease such as coronary artery
disease and peripheral vascular disease, still is the largest
cause of mortality in the western societies [1]. Surgical
treatment of atherosclerosis began in 1952, when Voorhees
et al. postulated to replace diseased blood vessels by
synthetic fabric [2]. This led to the widespread clinical
use of Dacron (polyethylene terephthalate (PET)) and
Te¯on (expanded polytetra-¯uoroethylene (ePTFE)) grafts
in cardiovascular surgery [3,4]. However, small-diameter
grafts (i.e. I.D. #6 mm) of both Dacron and Te¯on failed
rapidly due to occlusion [5,6] and when used to bypass
arteries showed rates of thrombosis greater than 40% after
6 months [7]. Recent strategies to increase graft patency
included protein coatings to minimize blood/biomaterial
interactions [8,9] and luminal seeding of the synthetic grafts
with various cell types to create a living hemocompatible
lining [10,11]. Although these reports have shown promis-
ing initial results, so far they did not come up with an `ideal'
solution. Synthetic grafts may still induce low-level foreign
body reaction and chronic in¯ammation [12], and as arti®-
cial materials they are at an increased risk for microbial
infections [13].
In an attempt to overcome these limitations cardiovascu-
lar tissue engineering is a new multidisciplinary approach to
create completely autologous, living replacement structures
such as heart valves and blood vessels. As viable structures,
tissue-engineered blood vessels represent a responsive and
self-renewing tissue with the inherent potential of healing
and remodelling according to the needs of the speci®c envir-
onment. Generally, most tissue engineering approaches rely
on bioabsorbable synthetic or natural materials as a scaffold-
ing to provide a temporary biomechanical pro®le until the
cells produce their own extracellular matrix. This has been
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especially true for tissue-engineered vascular grafts where
`hemodynamic' competence and suturing characteristics are
critical. However, previous tissue engineering concepts to
create vascular grafts have been limited by a lengthy in vitro
tissue formation and structural and mechanical immaturity
of the constructs at the time of in vivo implantation. We
hypothesized, that providing a `biomimetic' in vitro envir-
onment will accelerate tissue formation and yield more
mature, implantable vascular grafts. Therefore, we devel-
oped a novel pulse duplicator system in which the vascular
constructs were grown under controlled pulsatile ¯ow and
pressure conditions.
2. Materials and methods
2.1. Bioabsorbable vascular scaffolds
Non-woven polyglycolic-acid mesh (PGA, thickness: 1.0
mm, speci®c gravity: 69 mg cm23, Albany Int.) was coated
with a thin layer of poly-4-hydroxybutyrate (P4HB, MW:
1 £ 106, PHA 4400, TEPHA Inc., Cambridge, MA) by
dipping into a tetrahydrofuran solution (1% wt/vol.
P4HB). Following solvent evaporation, a continuous coat-
ing and physical bonding of adjacent ®bers was achieved.
P4HB is a biologically derived rapidly absorbable biopoly-
mer which is not only strong and pliable, but also thermo-
plastic (Tm 618C) so it can be moulded into almost any
shape. From the PGA/P4HB composite scaffold material
tubular scaffolds with an inner diameter (I.D.) of 0.5 cm
and a length of 4 cm were fabricated using a heat application
welding technique. The constructs were then cold gas ster-
ilized with ethylene oxide (Fig. 1).
2.2. Cell isolation and culture
Endothelial cells were obtained from segments of ovine
carotid artery (2±3 cm) using a collagenase instillation tech-
nique. The vascular tissue was incubated for 20 min at 378C,
5%CO2 in DMEM containing 0.2% collagenase type A
(Boehringer Mannheim) and 1% bovine serum albumin
(HyClone) and thereafter cultured in tissue culture ¯asks
(Corning Inc.) using Medium 199 (Gibco) supplemented
with 10% fetal bovine serum (HyClone), penicillin, strepto-
mycin (Gibco) and 50 IU/ml heparin (Promega). To obtain
myo®broblasts, the remaining de-endothelialized vessel
segments were minced and cultured on P100 dishes (Corn-
ing) in Dulbecco's modi®ed Eagle's medium (DMEM,
Gibco) supplemented with 10% fetal bovine serum
(HyClone), penicillin, streptomycin (Gibco). After migra-
tion of the myo®broblasts onto the dishes (after 5±7 days),
the cells were serially passaged and expanded in a humidi-
®ed incubator at 378C and 5% CO2. Suf®cient cell numbers
for cell seeding were obtained in pure culture after 21±28
days.
2.3. Cell seeding and in vitro culture in a pulse duplicator
system
Myo®broblasts (4.5±5:5 £ 106 per cm2) were seeded onto
the inner surfaces of the vascular scaffolds and cultured in
static nutrient medium (DMEM, Gibco) for 4 days in a
humidi®ed incubator (378C, 5% CO2). Thereafter the
constructs (n  24) were seeded with endothelial cells
(1.5±2:0 £ 106 per cm2 inner vascular surface), transferred
into a pulse duplicator system (`bioreactor', Fig. 2) and
grown under gradually increasing nutrient media ¯ow and
pressure conditions (125 ml/min at 30 mmHg to 750 ml/min
at 55 mmHg) for 4 (n  4), 7 (n  5), 14 (n  5), 21
(n  5), and 28 (n  5) days. Controls (n  24) were
grown in static nutrient media accordingly. The media
was changed every 7 days.
2.4. Microstructure
A representative portion of each vascular construct was
examined histologically by hematoxylin & eosin (H&E) and
factor VIII stain. Additional samples were ®xed in glutar-
aldehyde 2% (Sigma) for scanning electron microscopy
(SEM).
2.5. Tissue analysis
Biochemical assays were performed for analysis of cellu-
lar and extracellular components of the neo-tissue. Total
DNA was isolated and puri®ed by sequential organic extrac-
tions with phenol and phenol/chloroform/isoamyl alcohol
and quanti®ed by spectrophotometry [14]. For determina-
tion of total collagen content, tissue was completely acid-
digested and total 5-hydroxy-proline was measured [15].
The suture retention strength of the tissue-engineered
vascular grafts was measured using a mechanical tester
(Instron, Instron Corp., Canton, MA) and 4±0 prolene suture
material. The testing was carried out at room temperature
with a 100 Newton (N) load cell. The cross head speed was
20 mm/min. Rectangular shaped specimens of 20 mm gauge
length and a single suture (set at 5 mm distance from the
specimens edge) were measured and tensile force was
applied until complete rupture. Moreover, the burst strength
was measured by cannulation of the vascular constructs on a
specially designed system. They were pressurized with
phosphate buffered saline (PBS Dulbecco's, Gibco) and
the hydrostatic pressure was increased by 5 mmHg steps
until vessel failure.
2.6. Statistics
Result data were expressed as mean ^ standard error of
the mean. We used SPSS 8.0 software for statistical analy-
sis. An unpaired t-test (Student's t-test) was performed,
considering a P-value ,0.05 as statistically signi®cant.
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3. Results
3.1. Tissue microstructure
Histology of the tissue-engineered vascular constructs
revealed viable cellular tissue in all samples. There was
early organization of the tissue in a layered fashion with a
dense inner (luminal) layer and lesser cellularity in the outer
portions after 21 days in the pulsed vascular grafts, whereas
the static controls showed less tissue formation and organi-
zation at all time points. Factor VIII positive cells were
detectable on the luminal surfaces but a con¯uent layer of
endothelial cells was not seen. SEM demonstrated dense
tissue and a con¯uent smooth surface with cell orientation
in the direction of the ¯ow after 14 days whereas the
controls showed a less homogeneous surface at all time
points (Fig. 3). Biodegradation of the polymer scaffold
was detected by hydrolytic breakage and fragmentation of
the polymer ®bers.
3.2. Tissue analysis
The DNA- and Hydroxyproline assays showed a contin-
uous increase of cell mass and collagen content to 21 days
compared to signi®cantly lower values in the static controls
(DNA, P  0:004; Hydroxyproline P , 0:001) (Fig. 4).
3.3. Mechanical properties
There was a continuous increase of burst strength of the
vascular grafts grown in pulsatile ¯ow conditions up to more
than 300 mmHg in contrast to a substantial decrease over
time in the static controls reaching a signi®cant difference
among the groups after 21 days (P , 0:005). Similarly the
suture retention strength of the pulsed vessels was more than
5 times higher than of the controls. Both groups showed a
decrease in wall thickness over time (Table 1).
4. Discussion
The clinical use of arti®cial vascular grafts (Dacron,
ePTFE) to treat atherosclerotic disease represents a tremen-
dous progress in modern cardiovascular surgery and has
saved and improved millions of lives. Larger diameter vascu-
lar grafts have shown good long-term function for more than
10 years post-implantation [4]. In contrast, small caliber arti-
®cial grafts (i.e. I.D. ,6 mm) still tend to fail rapidly due to
thrombotic occlusion [5,6]. To address this problem, several
approaches to modify vascular graft surfaces such as seeding
of endothelial cells, impregnation or coating with biologi-
cally relevant proteins (e.g. collagen, albumin, ®bronection,
and laminin), and additives such as anticoagulants, growth
factors and antibiotics have been tested. Although signi®cant
advances with improved patency rates have been made, prin-
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Fig. 2. Schematic description of the pulsatile in vitro ¯ow system (bior-
eactor). The pulsatile ¯ow of the nutrient media is generated by periodical
expansion of a highly elastic membrane, de- and in¯ated by an air pump. In
the setting of the current study four tissue-engineered vascular grafts were
grown simultaneously.
Fig. 1. Vascular scaffold for tissue engineering fabricated from bioabsorb-
able PGA/P4HB polymer mesh using a heat application welding technique.
Note the highly porous luminal surface of the vascular graft (inner diameter
(I.D.) 0.5 cm).
cipally all these approaches comprise the implantation of
arti®cial, non-living materials into the body associated with
a substantial risk of foreign body reactions [13] and microbial
infections [14].
Tissue engineering applies the principles and methods of
engineering to biological sciences in an attempt to create
viable replacements of de®cient natural structures [16]. The
option of creating living blood vessels from autologous cells
offers many potential advantages compared to traditional
synthetic implants such as the absence of thrombotic occlu-
sion, the ability to grow, and the inherent potential of heal-
ing and remodelling according to the needs of the speci®c
environment.
In 1986, Weinberg and Bell were the ®rst to produce a
completely biological tissue-engineered vascular grafts
from animal collagen gels and bovine vascular cells [17].
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Fig. 3. Upper panel: Histology (H&E, £100) of tissue-engineered vessels at 21 days in vitro culture. Note the more organized tissue structure of the pulsed
vascular graft (B) with a dense luminal layer ( # ) and an outer portion with tight extracellular matrix formation (*) compared to the static control (A). Lower
panel: Scanning electron microscopy revealed a smooth, con¯uent luminal surface of the pulsed graft (D) in contrast to a less homogenous surface in the static
control (C). Note the orientation of the cells in the direction of ¯ow in D (white arrow direction of in vitro ¯ow).
Unfortunately, the mechanical properties of these grafts
were insuf®cient for in vivo implantation and even rein-
forced with a Dacron mesh failed to show adequate burst
strength. Other groups using a similar approach with human
collagen and human vascular cells encountered the same
mechanical limitations [18]. Recently, L'Heureux et al.
reported the feasibility of tissue-engineered blood vessels
with good mechanical properties based exclusively on the
use of cultured human cells without any synthetic or
exogenous biomaterials [19]. A disadvantage of this
approach was the fact that it took minimum 3 months
until implantable grafts were produced. Another excellent
concept reported by Niklason et al. used a biodegradable
PGA mesh as scaffolding for vascular grafts which were
wrapped around a silicone tubing, seeded with bovine
vascular cells and cultured for 2 months [20]. In vitro pulsa-
tile stress was indirectly applied to the construct by perfus-
ing the silicone tubing resulting in a periodical radial
distention of the vascular grafts.
In the present study we introduce a novel pulsatile in vitro
system to grow seeded vascular constructs under `biomi-
metic' ¯ow conditions. In contrast to previous studies the
pulsed ¯ow of nutrient media was directed immediately
through the vascular lumen, thereby generating direct
shear stress to the luminal surface as well as periodical
radial distension of the vessel wall. We anticipated, that
exposure of the developing vascular tissue to physical
signals similar to those encountered in vivo might result
in accelerated tissue maturation and formation of mechani-
cally stable, implantable vascular grafts.
We found that in comparison to standard static culture
conditions there was advanced tissue formation in an orga-
nized, layered fashion. In contrast to the controls, the tissue
was of compact composition without signs of a loose central
area. It is known from previous tissue engineering
approaches utilizing PGA scaffolds that the inner areas of
the generated neo-tissues frequently showed signs of cell
necrosis due to sub-optimal nutrient supply as well as an
hydrolytic degradation-related acidic local milieu. The
absence of this phenomenon in the current study may be
explained by an improved nutrient media tissue supply and
in parallel an increased `wash out' of the local acidotic tissue
milieu through utilization of our newly developed pulsatile
¯ow system. Regarding the luminal morphology of the tissue
engineered vascular grafts, there was a smoother, more
con¯uent surface in the pulsed grafts with homogenous cell
orientation in the direction of the ¯ow. However, although
factor VIII positive endothelial cells were detected on the
luminal surfaces, they were not completely con¯uent. This
may result from the fact that the vascular grafts were exposed
to increased in vitro ¯ow at a too early stage of the tissue
maturation process, resulting in a partial detachment and
`wash-out' of the endothelial cells.
The biochemical matrix analysis showed a continuous
increase of cell mass and collagen content in the pulsed
vascular grafts resulting in signi®cantly higher values
compared to the non-¯ow controls after 7 days. Collagen
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Table 1
Mechanical properties of the tissue-engineered vascular grafts (pulsatile ¯ow vs. static in vitro culture conditions)
Time in vitro (days) Burst strength (mmHg) Suture retention (g) Wall thickness (mm)
Pulsatile ¯ow Control (static) Pulsatile ¯ow Control (static) Pulsatile ¯ow Control (static)
7 177.5 (^10) 178.8 (^4) 74.5 (^4) 67.3 (^5) 0.85 (^0.08) 0.98 (^0.08)
14 240.0 (^28) 110.0 (^18) 56.8 (^5) 42.0 (^5) 0.75 (^0.05) 0.63 (^0.13)
21 262.5 (^26) 90.0 (^8) 64.8 (^3) 25.0 (^8) 0.63 (^0.04) 0.50 (^0.05)
28 326.3 (^24) 50.0 (^5) 64.3 (^5) 12.0 (^3) 0.73 (^0.04) 0.50 (^0.1)
Fig. 4. Cell- and collagen content of the tissue-engineered vascular grafts
(pulsatile ¯ow vs. static in vitro culture conditions).
represents the key extracellular matrix component for
mechanical stability and therefore is critical for the surgical
implantability of the tissue-engineered constructs. In accor-
dance with the superior extracellular matrix formation, the
mechanical characteristics of the pulsed vascular grafts
were more favourable regarding burst strength and suture
retention strength, resulting in properties appropriate for
surgical implantation after 3 weeks. In contrast, the static
controls showed a continuous loss of mechanical properties
in parallel to the biodegradation-related decrease of the
mechanical strength of the scaffold material. Since the scaf-
fold was supposed to provide only a temporary biomecha-
nical pro®le until the cells produce their own matrix proteins
the structural integrity and biomechanical pro®le of the
tissue-engineered vessels ultimately depended on this
matrix formation. The observed decrease of vascular wall
thickness in both groups is a known phenomenon in tissue
engineering re¯ecting a certain shrinkage of the constructs
during biodegradation of the polymer scaffold material.
These preliminary results demonstrate that acceleration
of the in vitro tissue formation and maturation of tissue-
engineered small caliber vascular grafts is feasible using a
`biomimetic' pulsatile ¯ow system. The grafts showed a
vessel-analogous tissue organization and mechanical prop-
erties appropriate for surgical implantation. Additional
studies focusing on in vivo application will have to be
performed to further validate the presented concept. Finally,
optimization of the in vitro conditions with regard to growth
factors, growth inhibitors and pressure loading conditions
are areas for future studies.
Acknowledgements
The authors wish to thank Dr David P. Martin, Tepha Inc,
Cambridge, MA, USA for providing the P4HB material and
his valuable cooperation as to the material aspects of this
study.
References
[1] American Heart Association. 2000 Heart and Stroke Statistical
Update. Dallas, TX, USA: American Heart Association, 1999.
[2] Voorhees AB, Jaretski A, Blakemore AH. The use of tubes
constructed from `Vinyon' N cloth in bridging arterial defects. Ann
Surg 1952;135:332±336.
[3] Szilagyi DE, Elliot JP, Smith RF, Reddy DJ, McPharlin M. A thirty-
year survey of reconstructive surgical treatment of aortoiliac occlu-
sive disease. J Vasc Surg 1986;3:421±436.
[4] Antiplatelet Trialist's Collaboration. Collaborative overview of
randomised trials of antiplatelet therapy ± II. Maintenance of vascular
graft or arterial patency by antiplatelet therapy. Br Med J
1994;308:159±168.
[5] Pevec WC, Darling C, L'Italien GJ, Abbott WM. Femoropopliteal
reconstruction with knitted nonvelour Dacron versus expanded poyte-
tra¯uoroethylene. J Vasc Surg 1992;16:60±65.
[6] Bergan JJ, Veith FJ, Bernhard VM, Yao JST, Flinn WR, Gupta SK,
Scher LA, Samson RH, Towne JB. Randomization of autogenous vein
and polytetra¯uoroethylene grafts in femorodistal reconstructions.
Surgery 1982;92:921±930.
[7] Sayers RD, Raptis S, Berce M, Miller JH. Long-term results of femor-
otibial bypass with vein or polytetra¯uoroethylene. Br J Surg
1998;85(7):934±938.
[8] Drury JK, Ashton TR, Cunningham JD, Maini R, Pollok JG. Experi-
mental and clinical experience with a gelatin impregnated Dacron
prosthesis. Ann Vasc Surg 1987;1:542±547.
[9] Freischlag J, Moore W. Clinical experience with a collagen-impreg-
nated knitted Dacron vascular graft. Ann Vasc Surg 1990;3:895±903.
[10] Williams SK, Rose DG, Jarrell BE. Microvascular endothelial cell
seeding of ePTFE vascular grafts: improved patency and stability of
the cellular lining. J Biomed Mat Res 1994;28:203±212.
[11] Pasic M, Muller-Glauser W, Odermatt B, Lachat M, Seifert B, Turina
M. Seeding with omental cells prevents late neointimal hyperplasia in
small-diameter dacron grafts. Circulation 1995;92:2605±2616.
[12] Greisler HP. Interactions at blood/material interface. Ann Vasc Surg
1990;4:98±103.
[13] Mertens RA, Ohara PJ, Hertzer NR, Krajewski LP, Beven EG. Surgi-
cal management of infrainguinal arterial prosthetic graft infections:
review of a thirty-®ve-year experience. J Vasc Surg 1995;21:782±
791.
[14] Preparation of genomic DNA from mammalian tissue. Current Proto-
cols in Molecular Biology (CPMB) 2.2. New York: John Wiley &
Sons, Inc, 1999.
[15] Bergman I, Loxley R. Two improved and simpli®ed methods for the
spectophotometric determination of hydroxyproline. Anal Chem
1963;35:1961±1965.
[16] Vacanti JP, Langer R. Tissue engineering: the design and fabrication
of living replacement devices for surgical reconstruction and trans-
plantation. Lancet 1999;354(I):32±34.
[17] Weinberg CB, Bell E. A blood vessel model constructed from
collagen and cultured vascular cells. Science 1986;231:397±400.
[18] L'Heureux N, Germain L, Labbe R, Auger FA. In vitro construction
of a human blood vessel from cultured vascular cells: a morphologic
study. J Vasc Surg 1993;17:499±509.
[19] L'Heureux N, Paquet S, Labbe R, Germain L, Auger FA. A comple-
tely biological tissue-engineered human blood vessel. FASEB J
1998;12:47±56.
[20] Niklason LE, Gao J, Abbott WM, Hirschi KK, Houser S, Marini R,
Langer R. Functional arteries grown in vitro. Science 1999;284:489±
493.
S.P. Hoerstrup et al. / European Journal of Cardio-thoracic Surgery 20 (2001) 164±169 169
